Drug Side Effects
Search
B-CELL LYMPHOMA REFRACTORY
B-CELL LYMPHOMA REFRACTORY
was reported 89 times
B-CELL LYMPHOMA REFRACTORY is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Bispecific CD20-directed CD3 T Cell Engager [EPC]
12
0.0030
1
Alkaloid [EPC]
7
0.0003
2
Topoisomerase Inhibitor [EPC]
20
0.0003
3
Alkylating Drug [EPC]
49
0.0002
4
CD19-directed Chimeric Antigen Receptor [EPC]
2
0.0002
5
CD20-directed Cytolytic Antibody [EPC]
56
0.0002
6
Platinum-based Drug [EPC]
24
0.0001
7
Nucleoside Metabolic Inhibitor [EPC]
23
0.0001
8
Phenothiazine [EPC]
2
0.0001
9
Xanthine Oxidase Inhibitor [EPC]
7
0.0000
10
Corticosteroid [EPC]
51
0.0000
11
Provitamin D2 Compound [EPC]
1
0.0000
12
Cholinergic Muscarinic Antagonist [EPC]
1
0.0000
13
Polyene Antifungal [EPC]
1
0.0000
14
Folate Analog Metabolic Inhibitor [EPC]
10
0.0000
15
Proteasome Inhibitor [EPC]
2
0.0000
16
Tetracycline-class Drug [EPC]
1
0.0000
17
Proton Pump Inhibitor [EPC]
7
0.0000
18
Thalidomide Analog [EPC]
6
0.0000
19
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
1
0.0000
20
Programmed Death Receptor-1 Blocking Antibody [EPC]
1
0.0000
21
Purine Antimetabolite [EPC]
1
0.0000
22
5-alpha Reductase Inhibitor [EPC]
1
0.0000
23
Fluoroquinolone Antibacterial [EPC]
1
0.0000
24
Interleukin-6 Receptor Antagonist [EPC]
1
0.0000
25
Selective T Cell Costimulation Modulator [EPC]
1
0.0000
26
Leukocyte Growth Factor [EPC]
1
0.0000
27
Azole Antifungal [EPC]
1
0.0000
28
beta-Adrenergic Blocker [EPC]
1
0.0000
29
Benzodiazepine [EPC]
1
0.0000